ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Adjuvant Therapies May Increase Time Between Surgeries for Recurrent Respiratory Papillomatosis

by Amy E. Hamaker • March 5, 2018

  • Tweet
  • Email
Print-Friendly Version

What are the most current perspectives on management of recurrent respiratory papillomatosis (RRP)?

Bottom line: RRP is incurable with current treatment modalities, but adjuvant therapies should be used when surgery cannot control the disease, with their efficacy limited to increasing the time interval between surgical procedures.

You Might Also Like

  • Systemic Bevacizumab Promising for Treatment-Resistant Recurrent Respiratory Papillomatosis
  • Laryngeal Distribution of Recurrent Respiratory Papillomatosis
  • Prevalence of Dysplasia with Recurrent Respiratory Papillomatosis Is High
  • Adult-Onset Recurrent Respiratory Papillomatosis May Be Associated with Number of Sexual Partners
Explore This Issue
March 2018

Background: RRP is a rare chronic disease caused by low-risk human papillomavirus (HPV) types 6 and 11, characterized by recurrent exophytic papillomas of the epithelial mucosa in the respiratory tract. RRP is difficult to manage, and there is currently no cure. Treatment is primarily focused on maintaining airway patency and voice quality. Patients often require multiple surgeries in a short amount of time and occasionally adjuvant therapy.

Study design: Literature review.

Synopsis: The authors found several current and future recommendations for management: The current standard of care for RRP management is surgical excision. Complete eradication is not necessarily the goal, as aggressive resection has been associated with increased HPV expression in nearby HPV-infected cells. A complication rate increase and a voice quality decrease have been reported for cold instruments versus lasers; for lasers, the shortest possible pulse and lowest possible power required are recommended. Microdebriders are often used in combination with lasers to first remove the bulk of the papilloma. Although office laser procedures are well tolerated in adult patients, patients with bulky or extensive papillomas or inadequate tolerance of the scope, and pediatric patients, are poor candidates.

Approximately 20% of RRP patients require adjuvant therapy. Current adjuvants include interferon therapy, rarely used due to side effect concerns; cidofovir, which may be initiated when surgical debulking is required every two to three months; bevacizumab, which has been shown to be relatively safe; celecoxib, a COX-2-selective non-steroidal anti-inflammatory drug; programmed cell death protein-1 inhibitors, which have shown clinical efficacy in HPV-associated HNSCC; gefitinib, an EGFR tyrosine kinase inhibitor; and the HPV vaccine Gardasil, which shows encouraging therapeutic results but requires more testing.

Citation: Ivancic R, Iqbal H, deSilva B, Pan Q, Matrka L. Current and future management of recurrent respiratory papillomatosis. Laryngoscope Inv Otol. 2018;3:22–34

Filed Under: Laryngology, Literature Reviews Tagged With: adjuvant therapy, recurrent respiratory papillomatosis, RRPIssue: March 2018

You Might Also Like:

  • Systemic Bevacizumab Promising for Treatment-Resistant Recurrent Respiratory Papillomatosis
  • Laryngeal Distribution of Recurrent Respiratory Papillomatosis
  • Prevalence of Dysplasia with Recurrent Respiratory Papillomatosis Is High
  • Adult-Onset Recurrent Respiratory Papillomatosis May Be Associated with Number of Sexual Partners

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Weaning Patients Off of PPIs
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Podcasts Becoming More Popular Method of Education for Otolaryngologists
    • How to Embrace Optimism in the Midst of the COVID-19 Pandemic
    • Tips on How to Approach Conversations with Patients about the COVID-19 Vaccine
    • Steps You Should Take to Protect Your Voice and Hearing During Telemedicine Sessions
    • Routine Postoperative Adjunct Treatments Unnecessary for Idiopathic Cerebrospinal Fluid Leaks

Polls

Have you spoken with your patients about receiving the COVID-19 vaccine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.